Marvel Commences Final Study Required Prior to Initiating Human Trials

Marvel Commences Final Study Required Prior to Initiating Human Trials

Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to announce that it has initiated the 4-week good laboratory practice (GLP) FDA investigational new drug (IND) enabling dose-ranging dog studies for its lead drug candidate MB-204.

"This dog study is the last of the two key primary animal studies we need to complete before entering phase 1 human clinical testing of our lead asset - MB-204," said Dr. Mark Williams, Chief Science Officer of Marvel Biosciences. "We are now planning our Phase 1 human trials, likely to be conducted in Australia upon the successful conclusion of this study and the previously commenced 4-week rat GLP study."

"We look forward to the completion of the rat and dog GLP studies of MB-204, and entering human trials, prior to the end of Q3 2023," said Rod Matheson, CEO of Marvel Biosciences. "We believe the profile of MB-204 is well-suited to address our primary markets, specifically depression and Alzheimer's disease. Owing to the immediate effect of the compound, we are confident that it will show the active effects early on in our clinical program."

In the United States, it is estimated that one in ten senior citizens over the age of 65 suffer from dementia. MB-204 is a novel solution to Alzheimer's that has similar properties to the Food and Drug Administration-approved drug, Istradefylline. MB-204 has, through the Company's studies, proven to be more effective and longer lasting than Istradefylline in pre-clinical studies.

MB-204 is a fluorinated derivative of the U.S. FDA-approved adenosine A2a receptor antagonist, Istradefylline. Both Istradefylline and MB-204 are highly active derivatives of caffeine, the most widely consumed psychoactive drug in the world. Caffeine consumption has been associated with a reduced risk of developing Parkinson's disease and Alzheimer's disease, as well as leading to an improved ability to concentrate.

About Marvel Biosciences Corp.

Marvel Biosciences Corp., and its wholly owned subsidiary, Marvel Biotechnology Inc., is a Calgary-based pre-clinical stage pharmaceutical development biotechnology company that utilizes a "drug redevelopment" approach to drug development. Historically, when a new class of drug is developed, it is optimized for a particular target, but typically only approved for a specific disease. Often, a new disease is identified which involves the same target, however, pending the remaining patent life, the originally approved drug may not have sufficient time left for it to be commercially viable to be developed for the new disease indication. Marvel develops new synthetic chemical derivatives of the original approved drug for the new disease indication. Patent protection is sought, as the new potential asset is developed by the Company. The Company believes the business model results in significantly less risk, cost and time to develop its assets compared to traditional biotechnology companies.

Marvel Biotechnology Inc. has currently developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.

Contact Information

Investor Relations:
Virtus Advisory Group
Tel: 416-644-5081
Email: info@virtusadvisory.com

Marvel Biosciences Corp.
J. Roderick (Rod) Matheson, Chief Executive Officer or
Dr. Mark Williams, President and Chief Science Officer
Tel: 403 770 2469

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

All information contained in this news release with respect to the Company and its subsidiary, (collectively, the "Parties") were supplied by Marvel, respectively, for inclusion herein and each parties' directors and officers have relied on each other for any information concerning such Party.

This news release may contain forward-looking statements and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of the Company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the expectations of the Company and include other risks detailed from time to time in the filings made by the Company under securities regulations.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. As a result, the Company cannot guarantee that the above events on the terms will occur and within the time disclosed herein or at all. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by Canadian securities law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/159134

News Provided by Newsfile via QuoteMedia

MRVL
The Conversation (0)
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience

The SNN Network Canada Virtual Event begins on Tuesday, December 7, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders including: Dave Barr, Sharon Wang, Paul Andreola, Becky Popoff, Harold Leishman, Sean MacGillis, and more!

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience

The SNN Network Canada Virtual Event begins on Tuesday, December 7, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders including: Dave Barr, Sharon Wang, Paul Andreola, Becky Popoff, Harold Leishman, Sean MacGillis, and more!

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
CSE:NUR

NuRAN Wireless Reports Audited Annual Financial Results

NuRAN Wireless Inc. (“NuRAN Wireless” or the “Company”) (CSE:NUR) (OTC:NRRWF) (FSE:1RN) , a leading supplier of mobile and broadband wireless solutions to connect the next billion, is pleased to announce its audited financial results for the twelve months ended October 31, 2018. All dollar amounts are expressed in Canadian currency.

NuRAN Wireless Inc.-Technology Leadership in the Making

Keep reading...Show less
Bitcoin Well Announces Bill Payments Via the Lightning Network and Unique User Signup Milestone

Bitcoin Well Announces Bill Payments Via the Lightning Network and Unique User Signup Milestone

(TheNewswire)

Bitcoin Well Inc.

Edmonton, Alberta July 16, 2024 TheNewswire Bitcoin Well Inc. (" Bitcoin Well " or the " Company ") ( TSXV: BTCW; OTCQB: BCNWF ), the non-custodial bitcoin business on a mission to enable independence announces the ability for customers in Canada to pay their household bills and credit cards with bitcoin on the Lightning Network, as well as the achievement of 21,000 unique users signed up to the Bitcoin Portal.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
RecycLiCo Battery Materials Inc. Granted European Unitary Patent for Innovative Lithium-Ion Battery Recycling Process

RecycLiCo Battery Materials Inc. Granted European Unitary Patent for Innovative Lithium-Ion Battery Recycling Process

-

RecycLiCo Battery Materials Inc. ("RecycLiCo" or the "Company"), TSX.V: AMY, OTCQB: AMYZF, FSE: ID4, a leader in sustainable lithium-ion battery recycling technology, is pleased to announce the registration of the European Unitary Patent (Patent Application No. 17870326.0) for its pioneering hydrometallurgical recycling solution. This patent grant solidifies the Company's intellectual property portfolio in Europe, a key market focused on electrification and sustainable battery technologies.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Forward Water Technologies Corp. Business Update: New Projects Initiated with Major Corporations in the Food and Beverage Sector

Forward Water Technologies Corp. Business Update: New Projects Initiated with Major Corporations in the Food and Beverage Sector

Forward Water Technologies Corp. ("FWTC") (TSXV:FWTC) has initiated new projects via direct customer contact in the food and beverage space to enable more efficient wastewater handling in the production of food and beverage products with globally positioned multinational manufacturers. FWTC has entered early planning stages for pilot or early commercial trials after being selected for evaluation by two unique clients. Projects, if successful, would represent a significant reduction in water usage for the manufacturing of products and simultaneously reduce the energy footprint currently required. This energy reduction would not only lead to cost savings but also have a major impact in reducing CO2 emissions

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Bitcoin Well Announces 87% Quarterly Growth in Q2 on the Bitcoin Portal

Bitcoin Well Announces 87% Quarterly Growth in Q2 on the Bitcoin Portal

(TheNewswire)

Bitcoin Well Inc.

Edmonton, Alberta TheNewswire - July 10, 2024 Bitcoin Well Inc. (" Bitcoin Well " or the " Company ") ( TSXV: BTCW ) ; ( OTCQB: BCNWF ), the non-custodial bitcoin business on a mission to enable independence, today announces that Bitcoin Portal volumes have grown by over 87% in Q2 2024 (CAD ~$16.85 million) compared to Q1 2024 (CAD ~$9 million) . With Bitcoin Portal volumes in the USA growing by over 260% in Q2 (CAD ~$0.4 million) compared to Q1 2024 (CAD ~$0.11 million) .

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
RecycLiCo Taiwan Battery Recycling Joint Venture Commences Production and Sales of Black Powder

RecycLiCo Taiwan Battery Recycling Joint Venture Commences Production and Sales of Black Powder

RecycLiCo Battery Materials Inc. (" RecycLiCo " or the " Company "), (TSX.V: AMY | OTCQB: AMYZF| FSE: ID4) a pioneer in the field of sustainable lithium-ion battery recycling technology, is pleased to announce that RecycLiCo Zenith Battery Materials Technology Co., the Company's joint venture with Zenith Chemical, has constructed a Stage 1 shredding facility at the site of its battery recycling plant in Taiwan and is now processing off-spec battery materials purchased from an established global battery manufacturer and selling the resulting black powder. The Joint Venture made its first shipment of black powder in late June and has already made arrangements for future shipments.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Bitcoin Well Announces the Ability to Sell Bitcoin Directly from Self Custody and 2024 Annual General and Special Meeting Results

Bitcoin Well Announces the Ability to Sell Bitcoin Directly from Self Custody and 2024 Annual General and Special Meeting Results

(TheNewswire)

Bitcoin Well Inc.

Edmonton, Alberta TheNewswire - July 3, 2024 Bitcoin Well Inc. (" Bitcoin Well " or the " Company ") ( TSXV: BTCW ) ; ( OTCQB: BCNWF ), the non-custodial bitcoin business on a mission to enable independence announces Auto Convert bitcoin addresses, which will give customers in the USA the ability to automatically convert bitcoin in their personal bitcoin wallets to dollars in their bank accounts in one single action, as well as the results from the Annual General and Special Meeting results.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×